SecSonar.com

Vir Biotechnology, Inc. (VIR)

Vir Biotechnology, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Vir Biotechnology, Inc. (VIR) is a Biotechnology company based in US with a market capitalization of $1.6B. Revenue declined 7.6% year-over-year and free cash flow was negative at -$396.6M. This page tracks VIR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 408 employees · IPO Oct 11, 2019

Valuation

Valuation & price

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.75$7.52$4.28Jul 25Dec 25Jul 26Jul 7, 25$5.27Jul 9, 25$5.93Jul 11, 25$5.65Jul 15, 25$5.30Jul 17, 25$5.49Jul 21, 25$5.52Jul 23, 25$5.85Jul 25, 25$5.65Jul 29, 25$5.25Jul 31, 25$5.07Aug 4, 25$5.10Aug 6, 25$5.08Aug 11, 25$4.28Aug 13, 25$4.57Aug 15, 25$4.52Aug 19, 25$4.36Aug 21, 25$4.38Aug 25, 25$4.38Aug 27, 25$5.23Aug 29, 25$4.94Sep 3, 25$5.51Sep 5, 25$5.27Sep 9, 25$5.24Sep 11, 25$5.23Sep 16, 25$4.86Sep 18, 25$5.18Sep 22, 25$5.27Sep 24, 25$5.26Sep 26, 25$5.49Sep 30, 25$5.71Oct 2, 25$5.66Oct 6, 25$5.59Oct 8, 25$6.05Oct 10, 25$5.80Oct 14, 25$5.72Oct 16, 25$5.80Oct 21, 25$6.27Oct 23, 25$5.78Oct 27, 25$6.19Oct 29, 25$5.91Oct 31, 25$5.96Nov 4, 25$5.25Nov 6, 25$5.12Nov 10, 25$5.37Nov 12, 25$5.71Nov 14, 25$5.63Nov 18, 25$5.50Nov 20, 25$5.56Nov 25, 25$6.44Nov 28, 25$6.42Dec 2, 25$5.63Dec 4, 25$6.78Dec 8, 25$6.58Dec 10, 25$6.55Dec 12, 25$6.69Dec 16, 25$6.48Dec 18, 25$5.93Dec 22, 25$6.01Dec 24, 25$6.11Dec 29, 25$5.98Jan 2, 26$5.94Jan 6, 26$5.96Jan 8, 26$5.95Jan 12, 26$5.92Jan 14, 26$6.82Jan 16, 26$6.06Jan 21, 26$6.94Jan 23, 26$7.56Jan 27, 26$7.69Jan 29, 26$7.78Feb 2, 26$7.71Feb 4, 26$7.50Feb 9, 26$7.28Feb 11, 26$7.42Feb 13, 26$7.47Feb 18, 26$7.83Feb 20, 26$7.56Feb 24, 26$9.49Feb 26, 26$9.32Mar 2, 26$9.34Mar 4, 26$9.56Mar 6, 26$9.55Mar 10, 26$9.88Mar 12, 26$9.48Mar 17, 26$9.48Mar 19, 26$9.38Mar 23, 26$8.84Mar 25, 26$8.99Mar 27, 26$8.40Mar 31, 26$8.96Apr 2, 26$9.06Apr 7, 26$9.17Apr 9, 26$9.83Apr 13, 26$9.31Apr 15, 26$10.46Apr 17, 26$10.75Apr 22, 26$10.67Apr 24, 26$10.37Apr 28, 26$10.28Apr 30, 26$10.22May 4, 26$10.18May 6, 26$10.29May 8, 26$9.12May 12, 26$9.40May 14, 26$9.09May 18, 26$8.77May 20, 26$8.88May 22, 26$9.19May 28, 26$9.55Jun 1, 26$9.03Jun 3, 26$8.77Jun 5, 26$8.65Jun 9, 26$8.51Jun 11, 26$8.52Jun 15, 26$8.61Jun 17, 26$9.30Jun 22, 26$9.57Jun 24, 26$9.95Jun 26, 26$10.03Jul 2, 26$10.04
$4.2852-week range$11.09
Loading valuation history…

Fundamentals

Key fundamentals

$1.6B

Market cap

-7.6%

Revenue growth (YoY)

82.9%

Gross margin

-$396.6M

Free cash flow (USD)

-$276M

Net debt

Net cash position

1.7%

Share dilution

—

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$149.0KFY 2018$868.0KFY 2019$711.0KFY 2020$67.2MFY 2021$1.1BFY 2022$1.6BFY 2023$86.2MFY 2024$74.2MFY 2025$68.6M
$149K$68.6M

Free cash flow by year

2017 → 2025

FY 2017$-69.1MFY 2018$-102.3MFY 2019$-138.6MFY 2020$-197.5MFY 2021$-69.4MFY 2022$1.6BFY 2023$-800.4MFY 2024$-453.7MFY 2025$-396.6M
-$69.1M-$396.6M

Gross margin by year

2021 → 2025

FY 202153.1%FY 202261.6%FY 2023-564.7%FY 2024-545.0%FY 202582.9%
53.1%82.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

4

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector AppointmentJun 10, 2026Filing
  • Insider sellInsider Sell $4K · 10b5-1 PlanSabatini Brent · SVP, Chief Accounting Officer · $3.6KJun 2, 2026Filing
  • Insider sellInsider Sell $30K · 10b5-1 PlanNapolitano Janet · Director · $30.2KJun 2, 2026Filing
  • 8-K eventBoard Member DepartureMay 28, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Insider sellInsider Sell $221K · 10b5-1 PlanSATO VICKI L · Director · $221KMay 4, 2026Filing
  • 8-K eventExecutive DepartureApr 10, 2026Filing
  • Insider sellInsider Sell $664K · 10b5-1 PlanDe Backer Marianne · Director, President and CEO · $664.4KApr 7, 2026Filing
  • Insider sellInsider Sell $200K · 10b5-1 PlanSATO VICKI L · Director · $199.6KApr 2, 2026Filing

Questions

Frequently asked questions

What is Vir Biotechnology, Inc.'s market cap?

Vir Biotechnology, Inc. (VIR) has a market capitalization of $1.6B.

Are insiders buying VIR stock?

SEC Form 4 filings show no open-market insider buys at Vir Biotechnology, Inc. in the last 90 days (4 sells).

Same arena

Related companies in Biotechnology

RXRX

Recursion Pharmaceuticals, Inc.

$1.6B

INVA

Innoviva, Inc.

$1.6B

NTLA

Intellia Therapeutics, Inc.

$1.6B

VRDN

Viridian Therapeutics, Inc.

$1.6B

NUVB

Nuvation Bio Inc.

$1.6B

OCS

Oculis Holding AG

$1.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.